Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 431

1.

Docetaxel (Taxotere) in the neo-adjuvant setting in non-small-cell lung cancer.

Mattson K.

Ann Oncol. 1999;10 Suppl 5:S69-72.

PMID:
10582143
[PubMed - indexed for MEDLINE]
2.

The role of docetaxel (Taxotere) as a single agent or in combination before local treatment of non-small cell lung cancer.

Harper P.

Semin Oncol. 1997 Aug;24(4 Suppl 14):S14-30-S14-32.

PMID:
9335522
[PubMed - indexed for MEDLINE]
3.

Docetaxel as neoadjuvant therapy for radically treatable stage III non-small-cell lung cancer: a multinational randomised phase III study.

Mattson KV, Abratt RP, ten Velde G, Krofta K.

Ann Oncol. 2003 Jan;14(1):116-22.

PMID:
12488303
[PubMed - indexed for MEDLINE]
Free Article
4.

Docetaxel (Taxotere) and neoadjuvant chemotherapy for non-small cell lung cancer.

Mattson K.

Semin Oncol. 1999 Jun;26(3 Suppl 10):25-8. Review.

PMID:
10437748
[PubMed - indexed for MEDLINE]
5.

Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma.

Koukourakis MI, Bahlitzanakis N, Froudarakis M, Giatromanolaki A, Georgoulias V, Koumiotaki S, Christodoulou M, Kyrias G, Skarlatos J, Kostantelos J, Beroukas K.

Br J Cancer. 1999 Aug;80(11):1792-6.

PMID:
10468298
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Induction combination chemotherapy with docetaxel and carboplatin in advanced non-small-cell lung cancer.

Herse B, Dalichau H, Wörmann B, Hemmerlein B, Schmidberger H, Hess CF, Hannemann P, Criée CP, Hiddemann W, Griesinger F.

Thorac Cardiovasc Surg. 1998 Oct;46(5):298-302.

PMID:
9885122
[PubMed - indexed for MEDLINE]
7.
8.

Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial.

Betticher DC, Hsu Schmitz SF, Tötsch M, Hansen E, Joss C, von Briel C, Schmid RA, Pless M, Habicht J, Roth AD, Spiliopoulos A, Stahel R, Weder W, Stupp R, Egli F, Furrer M, Honegger H, Wernli M, Cerny T, Ris HB.

J Clin Oncol. 2003 May 1;21(9):1752-9.

PMID:
12721251
[PubMed - indexed for MEDLINE]
Free Article
9.

Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.

Hainsworth JD, Greco FA.

Semin Oncol. 1995 Dec;22(6 Suppl 15):45-9.

PMID:
8643970
[PubMed - indexed for MEDLINE]
10.

Concurrent two-dimensional radiotherapy and weekly docetaxel in the treatment of stage III non-small cell lung cancer: a good local response but no good survival due to radiation pneumonitis.

Onishi H, Kuriyama K, Yamaguchi M, Komiyama T, Tanaka S, Araki T, Nishikawa K, Ishihara H.

Lung Cancer. 2003 Apr;40(1):79-84.

PMID:
12660011
[PubMed - indexed for MEDLINE]
11.

Neoadjuvant chemotherapy with docetaxel in non--small cell lung cancer.

Mattson K.

Semin Oncol. 2001 Jun;28(3 Suppl 9):33-6.

PMID:
11441413
[PubMed - indexed for MEDLINE]
12.

Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 107 consecutive patients with limited- and extensive-stage non-small-cell lung cancer.

Fetscher S, Brugger W, Engelhardt R, Kanz L, Hasse J, Frommhold H, Wenger M, Lange W, Mertelsmann R.

Ann Oncol. 1997 Jan;8(1):57-64.

PMID:
9093708
[PubMed - indexed for MEDLINE]
Free Article
13.

Docetaxel: a review of its use in non-small cell lung cancer.

Comer AM, Goa KL.

Drugs Aging. 2000 Jul;17(1):53-80. Review.

PMID:
10933515
[PubMed - indexed for MEDLINE]
14.

A systematic overview of chemotherapy effects in non-small cell lung cancer.

Sörenson S, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):327-39. Review.

PMID:
11441939
[PubMed - indexed for MEDLINE]
15.

Phase II study of docetaxel and cisplatin in advanced non-small-cell lung cancer.

Zalcberg J, Millward M, Bishop J, McKeage M, Zimet A, Toner G, Friedlander M, Barter C, Rischin D, Loret C, James R, Bougan N, Berille J.

J Clin Oncol. 1998 May;16(5):1948-53.

PMID:
9586914
[PubMed - indexed for MEDLINE]
Free Article
16.

Concurrent paclitaxel-cisplatin and twice-a-day irradiation in stage IIIA and IIIB NSCLC shows improvement in local control and survival with acceptable hematologic toxicity.

Pisch J, Moskovitz T, Esik O, Homel P, Keller S.

Pathol Oncol Res. 2002;8(3):163-9. Epub 2003 Jan 6.

PMID:
12515995
[PubMed - indexed for MEDLINE]
Free Article
17.
18.

Docetaxel and concurrent radiotherapy after two cycles of induction chemotherapy with cisplatin and vinorelbine in patients with locally advanced non-small-cell lung cancer. A phase II trial conducted by the Groupe Francais de Pneumo-Cancerologie (GFPC).

Vergnenègre A, Daniel C, Léna H, Fournel P, Kleisbauer JP, Le Caer H, Letreut J, Paillotin D, Pérol M, Bouchaert E, Preux PM, Robinet G; Groupe Francais de Pneumo-Cancerologie.

Lung Cancer. 2005 Mar;47(3):395-404.

PMID:
15713523
[PubMed - indexed for MEDLINE]
19.

Docetaxel and irinotecan, alone and in combination, in the treatment of non-small cell lung cancer.

Adjei AA, Argiris A, Murren JR.

Semin Oncol. 1999 Oct;26(5 Suppl 16):32-40; discussion 41-2. Review.

PMID:
10585007
[PubMed - indexed for MEDLINE]
20.

Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxel.

Chen YM, Shih JF, Lee CS, Chen MC, Lin WC, Tsai CM, Perng RP.

Lung Cancer. 2003 Feb;39(2):209-14.

PMID:
12581575
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk